Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02901899
Title Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

fallopian tube cancer

peritoneal carcinoma

ovary epithelial cancer

Therapies

Guadecitabine + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.